News

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7034.801 (Published 30 March 1996) Cite this as: BMJ 1996;312:801
  1. Martin J Prince, lecturer in psychiatrya,
  2. Anne S Bird, consultant psychiatristb,
  3. Robert A Blizard, lecturer in statisticsc,
  4. Anthony H Mann, professor of epidemiological psychiatrya
  1. a Section of Epidemiology and General Practice, Institute of Psychiatry, London SE5 8AF
  2. b Royal Free Hospital, London NW3 2QG
  3. c Academic Department of Psychiatry, Royal Free Hospital, London NW3 2QG
  1. Correspondence to: Dr Prince.
  • Accepted 5 December 1995

Abstract

Objective: To establish whether initiation of treatment with diuretic or β blocker is associated over 54 months with change in cognitive function.

Design: A cognitive substudy, nested within a randomised, placebo controlled, single blind trial.

Setting: 226 general practices from the Medical Research Council's general practice research framework.

Subjects: A subset of 2584 subjects sequentially recruited from among the 4396 participants aged 65-74 in the trial of treatment of hypertension in older adults. The 4396 subjects were randomised to receive diuretic, β blocker, or placebo. Subjects had mean systolic pressures of 160-209 mm Hg and mean diastolic pressures <115 mm Hg during an eight week run in.

Outcome measures: The rate of change in paired associate learning test (PALT) and trail making test part A (TMT) scores (administered at entry and at 1, 9, 21, and 54 months) over time.

Results: There was no difference in the mean learning test coefficients (rate of change of score over time) between the three treatments: diuretic -0.31 (95% confidence interval -0.23 to -0.39), β blocker -0.33 (-0.25 to -0.41), placebo -0.30, (-0.24 to -0.36). There was also no difference in the mean trail making coefficients (rate of change in time taken to complete over time) between the three groups: diuretic -2.73 (95% confidence interval -3.57 to -1.88), β blocker -2.08 (-3.29 to -0.87), placebo -3.01, (-3.69 to -2.32). A less conservative protocol analysis confirmed this negative finding.

Conclusion: Treating moderate hypertension in older people is unlikely to influence, for better or for worse, subsequent cognitive function.

Key messages

  • Key messages

  • Studies have shown that treating hypertension in older adults reduces cardiovascular mortality and morbidity

  • Treating moderate hypertension with either diuretic or β blocker does not seem to influence cognitive function

  • Concerns about damaging cognition should not deter doctors from treating hypertension in older patients

  • Age should no longer be a factor in the decision to initiate antihypertensive treatment

Footnotes

  • Funding Dr Prince holds a clinical training fellowship in epidemiology funded by the Wellcome Trust.

  • Conflict of interest None.

  • Accepted 5 December 1995
View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe